Following the trend of the last few quarters, the medical device sector still demonstrated high levels of M&A and financing activity in Q4, despite a downtick from the previous year. Less than half of our tracked sectors in the medical device space witnessed positive stock price momentum versus the S&P 500, signaling an industry correction from the pandemic highs. Multiple sectors still outperformed, however, including aesthetics, lab diagnostics, and radiation therapy. Transaction levels indicated a high degree of stability, tracking roughly with Q3.
Month: January 2023
MedDevNews, Q3 2021
The medical device sector demonstrated sustained high levels of M&A and financing activity in Q3. Over two thirds of our tracked sectors in the medical device space witnessed positive stock price momentum versus the S&P 500, further demonstrating positive sector trajectory and outlook. Discussions with numerous strategic acquirers and private companies during the quarter and particularly following Labor Day, indicated that despite the Delta surge, there were a large number of assets on the market and buyer M&A teams are very busy and actively looking at several potential acquisitions on average.
MedDevNews, Q2 2021
The medical device sector demonstrated sustained levels of activity as seen through the continued robust M&A and financing activity in Q2. Over three quarters of our tracked sectors in the medical device space witnessed positive stock price momentum versus the S&P 500, further exemplifying prosperous sector performance and trajectory.
MedDevNews, Q1 2021
Q1 2021 Saw Overall Growth in Transaction Activity
The rise in M&A activity and continued financing activity in Q1 was a function of improved buyer and investor optimism as patient volumes and surgical procedures began to rebound. Half of our tracked sectors in the medical device space witnessed positive stock price momentum against the S&P 500, which brings greater access to financing options and boosts appetites for M&A.